US EditionPublished • loading... • Updated
Biotech Firms Say AI Is Closing The Talent Gap In Drug Discovery And Gene Editing
Summary by digitalmarketreports.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biotech Firms Say AI Is Closing The Talent Gap In Drug Discovery And Gene Editing
AI As A Force Multiplier In BiotechExecutives from Insilico Medicine and GenEditBio said this week that artificial intelligence is helping the industry tackle problems that have gone untreated for years because of a shortage of skilled labor, even as modern biotech already has tools to edit genes and design drugs. Speaking at Web Summit Qatar, Insilico president Alex Aliper said the missing ingredient has long been finding enough capable people …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
